rs397515538

Variant summary

Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_001024630.4(RUNX2):​c.90delC​(p.Ser31ProfsTer9) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000125 in 1,605,386 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 30)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

RUNX2
NM_001024630.4 frameshift

Scores

Not classified

Clinical Significance

Likely pathogenic criteria provided, multiple submitters, no conflicts P:2

Conservation

PhyloP100: -0.871

Publications

6 publications found
Variant links:
Genes affected
RUNX2 (HGNC:10472): (RUNX family transcription factor 2) This gene is a member of the RUNX family of transcription factors and encodes a nuclear protein with an Runt DNA-binding domain. This protein is essential for osteoblastic differentiation and skeletal morphogenesis and acts as a scaffold for nucleic acids and regulatory factors involved in skeletal gene expression. The protein can bind DNA both as a monomer or, with more affinity, as a subunit of a heterodimeric complex. Two regions of potential trinucleotide repeat expansions are present in the N-terminal region of the encoded protein, and these and other mutations in this gene have been associated with the bone development disorder cleidocranial dysplasia (CCD). Transcript variants that encode different protein isoforms result from the use of alternate promoters as well as alternate splicing. [provided by RefSeq, Jul 2016]
RUNX2 Gene-Disease associations (from GenCC):
  • cleidocranial dysplasia 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 18 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. There are 132 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 6-45422617-GC-G is Pathogenic according to our data. Variant chr6-45422617-GC-G is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 929063.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RUNX2NM_001024630.4 linkc.90delC p.Ser31ProfsTer9 frameshift_variant Exon 3 of 9 ENST00000647337.2 NP_001019801.3 Q13950-1
RUNX2NM_001369405.1 linkc.48delC p.Ser17ProfsTer9 frameshift_variant Exon 1 of 7 NP_001356334.1
RUNX2NM_001015051.4 linkc.90delC p.Ser31ProfsTer9 frameshift_variant Exon 3 of 8 NP_001015051.3 Q13950-3
RUNX2NM_001278478.2 linkc.48delC p.Ser17ProfsTer9 frameshift_variant Exon 1 of 6 NP_001265407.1 Q32MY8A0A0D9SEN7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RUNX2ENST00000647337.2 linkc.90delC p.Ser31ProfsTer9 frameshift_variant Exon 3 of 9 NM_001024630.4 ENSP00000495497.1 Q13950-1

Frequencies

GnomAD3 genomes
AF:
0.00000661
AC:
1
AN:
151218
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0000243
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
6.88e-7
AC:
1
AN:
1454168
Hom.:
0
Cov.:
34
AF XY:
0.00
AC XY:
0
AN XY:
723226
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
33212
American (AMR)
AF:
0.00
AC:
0
AN:
43478
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26022
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39138
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85004
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52310
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5754
European-Non Finnish (NFE)
AF:
9.02e-7
AC:
1
AN:
1109124
Other (OTH)
AF:
0.00
AC:
0
AN:
60126
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.225
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.00000661
AC:
1
AN:
151218
Hom.:
0
Cov.:
30
AF XY:
0.0000136
AC XY:
1
AN XY:
73760
show subpopulations
African (AFR)
AF:
0.0000243
AC:
1
AN:
41120
American (AMR)
AF:
0.00
AC:
0
AN:
15150
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5078
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4792
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10478
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
310
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67840
Other (OTH)
AF:
0.00
AC:
0
AN:
2076
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Cleidocranial dysostosis Pathogenic:1
Jul 11, 2019
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: RUNX2 c.90delC (p.Ser31ProfsX9) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay (NMD), which are commonly known mechanisms for disease. However, downstream from the variant, there is a second ATG codon in an appropriate context for translational initiation, and at least one in vitro study has described that a construct containing only the second ATG codon (i.e. Met39) was nearly as active as the WT construct containing both; on the other hand, the same study demonstrated that deletion of the first 38 amino acid residues led to a partial decrease in transactivation activity (PMID: 9632804). The variant was observed in 1/31166 control chromosomes (gnomAD database, genome dataset). To our knowledge, no occurrence of c.90delC in individuals affected with Cleidocranial Dysplasia (CCD) and no experimental evidence demonstrating its impact on protein function have been reported. However, different variant, affecting the same nucleotide position, and resulting in a similar protein level change (i.e. a frameshift), RUNX2 c.90dupC (p.Ser31Leufs), has been described in the literature in a proband with mild CCD, and with significant intrafamilial variability in expressivity, leading the authors to interpret this variant as a hypomorphic allele, which could be possibly explained by the utilization of the downstream ATG codon for translational initiation (PMID: 10545612). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant of interest could possibly represent a hypomorphic variant associated with milder phenotype, or potentially even a typical truncating variant associated with a more severe phenotype (based on NMD), therefore it was classified as likely pathogenic. -

Cleidocranial dysostosis;C3549874:Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome Pathogenic:1
-
Juno Genomics, Hangzhou Juno Genomics, Inc
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PM2_Supporting+PVS1 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.87
Mutation Taster
=4/196
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs397515538; hg19: chr6-45390354; COSMIC: COSV61839441; COSMIC: COSV61839441; API